Stultz Katherine V 4
4 · Kronos Bio, Inc. · Filed Apr 11, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Stultz Katherine V
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-04-10+68,000→ 68,000 totalExercise: $1.29Exp: 2033-04-09→ Common Stock (68,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in three equal annual installments following the date of grant.